Catalog Number PFRT01 |
Device Problem
Material Erosion (1214)
|
Patient Problems
Bleeding (1738); Erosion (1750); Pain (1994); Scar Tissue (2060); Other (for use when an appropriate patient code cannot be identified) (2200); Surgical procedure (2357)
|
Event Type
Injury
|
Event Description
|
It was reported by an attorney that the patient underwent a gynecological procedure on (b)(6) 2005 and mesh was implanted.It was reported that she experienced pain, erosion of her internal bodily tissue and other injuries following the procedure.It was reported that the patient has undergone multiple surgeries and revisionary procedures.No additional information was provided.
|
|
Manufacturer Narrative
|
(b)(4).Should additional information be obtained, a supplemental 3500a form will be submitted accordingly.(b)(4).Total number of events - 306.Gynecare prolift +m anterior pelvic floor repair system - 13.Gynecare prolift +m pelvic floor repair system - 7.Gynecare prolift +m posterior pelvic floor repair system - 20.Gynecare prolift +m total pelvic floor repair system - 22.Gynecare prolift anterior pelvic floor repair system - 69.Gynecare prolift pelvic floor repair system - 47.Gynecare prolift posterior pelvic floor repair system - 35.Gynecare prolift total pelvic floor repair system - 63.Gynecare prosima pelvic floor repair system - 30.
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
During the initial procedure, the patient underwent an anterior and posterior repair, vaginal vault suspension.Following the insertion, the patient experienced pain, erosion, urinary problems, bleeding and vaginal scarring.(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).Reporting period (b)(6) 2014.Supplemental report 14.
|
|
Manufacturer Narrative
|
(b)(4).Reporting period april 1, 2014 through may 31, 2014.
|
|
Manufacturer Narrative
|
Date sent to the fda: 02/22/2017.(b)(4).Reporting period april 1, 2014 through may 31, 2014.Supplemental report 16.
|
|
Manufacturer Narrative
|
Date sent to the fda: 04/19/2017.Ethicon mdr summary reporting exemption (b)(4).Reporting period april 1, 2014 through may 31, 2014.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period (b)(4) 2014.Supplemental report 18.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period april 1, 2014 through may 31, 2014.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4) reporting period (b)(6) 2014 through (b)(6) 2014 supplemental report 23 - attachment: [(b)(6) 2014 otp supplemental 23.Xlsx].
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period april 1, 2014 through may 31, 2014.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period april 1, 2014 through may 31, 2014.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period april 1, 2014 through may 31, 2014.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period april 1, 2014 through may 31, 2014.
|
|
Manufacturer Narrative
|
Date sent to fda: 12/26/2018.Ethicon mdr summary reporting exemption e2013037.Reporting period april 1, 2014 through may 31, 2014.
|
|
Manufacturer Narrative
|
Date sent to fda: 02/12/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period april 1, 2014 through may 31, 2014.
|
|
Manufacturer Narrative
|
Date sent to fda: 04/24/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period april 1, 2014 through may 31, 2014.
|
|
Search Alerts/Recalls
|